Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
92 hedge funds and large institutions have $101M invested in Enzo Biochem, Inc. in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 7 closing their positions.
2,656% more call options, than puts
Call options by funds: $496K | Put options by funds: $18K
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
12% more capital invested
Capital invested by funds: $90.4M → $101M (+$10.7M)
10% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 29
7% more funds holding
Funds holding: 86 → 92 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.89M |
| 2 |
Renaissance Technologies
New York
|
+$1.95M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$1.61M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.6M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRC
Platte River Capital
Denver,
Colorado
|
-$668K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$625K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$586K |
| 4 |
CCM
Corsair Capital Management
New York
|
-$352K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$245K |
ENZ Hedge Fund Activity: Q3 2014 in Review
92 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2014, worth a combined $101M — up 12% from $90.4M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ENZ positions and 7 closed out — a net gain of 7 holders — while 32 added to existing stakes and 29 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $2.89M. The largest seller was Platte River Capital, cutting an estimated $668K.
- 92 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2014, up from 86 in Q2 2014.
- Funds reported $101M of Enzo Biochem, Inc. stock for Q3 2014, up 12% quarter-over-quarter.
- 14 funds opened new Enzo Biochem, Inc. positions in Q3 2014 and 7 closed out, a net change of +7 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2014 was Wellington Management Group, an estimated $2.89M added.
- The largest Enzo Biochem, Inc. seller in Q3 2014 was Platte River Capital, an estimated $668K sold.
Based on aggregated 13F filings for Q3 2014.